1 EVERYONE S GUIDE FOR CANCER THERAPY Malin Dollinger, MD, Ernest H. Rosenbaum, MD, Margaret Tempero, MD, and Sean Mulvihill, MD 4th Edition 2001 Uterus: Endometrial Carcinoma Jeffrey L. Stern, MD Endometrial cancer-carcinoma of the lining of the uterus-is the most common gynecologic malignancy and accounts for about 13 percent of all malignancies occurring in women. There are about 34,000 cases of endometrial cancer diagnosed in the United States each year, but encouragingly, there has been a significant decrease in the number of women who develop endometrial cancer each year since Similarly, the death rate from endometrial cancer has steadily declined from 1950 to 1985, falling more than 60 percent. Since this cancer is usually diagnosed at an early stage, the cure rate is high, with a five-year survival of 85 percent. Types All endometrial carcinomas arise from the glands of the lining of the uterus. Adenocarcinoma accounts for 75 percent of all endometrial carcinoma. Endometrial adenocarcinomas that contain benign or malignant squamous cells are known as adenocanthomas and adenosquamous carcinomas respectively and account for 30 percent of endometrial cancers. The remaining types of endometrial carcinoma have a poorer prognosis. Three percent have a clear cell carcinoma, and about 1 percent has a papillary carcinoma.
2 Uterine sarcoma is another kind of uterine malignancy. (See "Uterus: Uterine Sarcomas"). How It Spreads From where it arises in the lining of the uterus, endometrial carcinoma eventually invades the wall of the uterus and may involve the cervix. With time, it can grow through the wall of the uterus into the surrounding tissues (the parametrium), the bladder and the rectum. It can also spread by the lymphatic system to the vagina, fallopian tubes, ovaries, the pelvic and aortic lymph nodes and to the lymph nodes in the groin and above the collarbone (supraclavicular). Like ovarian carcinoma, endometrial cancer can also spread throughout the abdominal cavity and occasionally through the bloodstream to the lung, liver and brain. How rapidly it spreads depends on the grade (histologic virulence) of the cancer. Endometrial cancer is often associated with a primary carcinoma of the ovary. (See "Ovarian Germ Cell Cancer"). What Causes It Unknown. RISK FACTORS The use of birth control pills and postmenopausal hormone replacement therapy with estrogen and progesterone, decrease the risk of developing endometrial cancer by half.
3 At Significantly Higher Risk Obesity greater than 50 pounds (23 kg) over ideal body weight (10 times as likely). Postmenopausal women. Menopause after age 52 (2.4 times as likely). Lack of children (twice as likely). Women with hypertension (twice as likely). Diabetics (2.8 times). Women who do not ovulate, those with polycystic ovaries (Stein-Leventhal syndrome). Estrogen replacement therapy without supplemental progesterone (seven times as likely). History of pelvic radiation therapy (eight times). SCREENING Screening for endometrial carcinoma is not as satisfactory as screening for cancer of the cervix because of the inaccessibility of the uterine cavity. Pap smears detect only a small percentage of endometrial cancers. There have been studies of other screening methods that can be performed in the doctor's office, with several showing the benefit of using endometrial biopsies to screen high-risk women who have no symptoms. This procedure is associated with some discomfort, however, and may not be cost-effective in the absence of risk factors. A uterine sonogram (ultrasound) maybe suggestive of uterine cancer if the lining of the uterus cavity demonstrates increased thickness. Routine annual screening for women without symptoms is not recommended by the American College of Obstetricians and Gynecologists.
4 COMMON SIGNS AND SYMPTOMS In 90 percent of cases, there is abnormal uterine bleeding, ranging from insignificant staining to a hemorrhage. There may also be pain in the pelvis, back or legs, bladder or rectal symptoms, weight loss and general weakness. Five percent of women will have no symptoms. DIAGNOSIS Physical Examination On a gynecologic examination, the external genitalia are usually normal. The cervix may be involved with cancer (Stage II), and the vagina may also be involved (Stage III). Occasionally the uterus will be enlarged or softened and masses may be detected in the pelvis (a rectal examination is an important aspect of the pelvic examination). Enlarged lymph nodes in the neck and groin. Enlarged liver, abdominal mass or excessive abdominal fluid (ascites). Blood and Other Tests Complete blood count. Serum liver and kidney tests. Serum CA-125 is produced by a small percentage of women with endometrial carcinoma, usually advanced, which can be useful in follow up to detect recurrences. Imaging A uterine sonogram with thickened endometrial cavity may be suggestive of a uterine cancer. CT scan of the abdomen and MRI scan of the pelvis may be useful for determining the extent of the cancer in the pelvis, the presence of ovarian disease and the presence of
5 involved pelvic and aortic lymph nodes and liver metastases. It is usually performed for advanced cancer. Chest x-ray. Endoscopy and Biopsy The definitive diagnosis is made on an endometrial biopsy, which involves a small scraping of the uterus and is usually performed in the doctor's office. A dilation and curettage (D&C) is required for some women-those who have biopsy-proven endometrial hyperplasia (see below), those who have an insufficient specimen on an office biopsy or who can't have an endometrial biopsy done in the office because of a small cervical opening or discomfort. STAGING Cancer of the uterus is surgically staged. Between 70 and 80 percent of all endometrial cancers are Stage I. In 1988, the International Federation of Gynecologists and Obstetricians (FIGO) staging was revised to include the grade of the cancer (degree of virulence) determined on microscopic examination. The cancers are divided into three grades, with Grade 1 (welldifferentiated) having the best prognosis and Grade 3 (poorly-differentiated) having the poorest. ENDOMETRIAL CANCER PRECURSORS Endometrial hyperplasia, an overgrowth of the lining of the uterus, is a precursor to the development of cancer. This disorder tends to progress from a simple, benign hyperplasia confined to the lining of the uterus, to more severe atypical forms of hyperplasia and eventually
6 to an invasive malignancy. The risk factors for endometrial hyperplasia are similar to those of endometrial carcinoma. Abnormal uterine bleeding is usually the first symptom. The diagnosis is made by evaluating the lining of the uterus by biopsy or dilation and curettage (D&C). Treatment depends on the degree of hyperplasia, the presence of nuclear atypia, the age of the woman and her reproductive desires. Total abdominal hysterectomy and removal of both tubes and both ovaries is recommended for postmenopausal women and women who have completed childbearing. Women who want to keep their reproductive organs can be treated with a number of different oral progestational hormones for several months. The cure rate depends on the degree of hyperplasia and the sensitivity of the endometrium to the progestational therapy. TREATMENT OVERVIEW Treatment of endometrial carcinoma is based primarily on the stage and grade of the cancer. The standard therapy is an abdominal hysterectomy with removal of both fallopian tubes and ovaries, removal of pelvic and aortic lymph nodes and washings from the abdominal cavity to look for malignant cells. Many gynecologic oncologists also recommend obtaining a specimen from the cancer for analysis of its estrogen and progesterone receptor content in women with advanced stage disease.
7 The receptor content has prognostic value and may be useful in the selection of hormone therapy for recurrent or metastatic cancer. Surgery Most gynecologic oncologists recommend a midline abdominal incision to gain access to the upper abdomen. However, laparoscopic surgery (minimal invasive surgery) including a hysterectomy, removal of both tubes and ovaries, removal of the pelvic and para-aortic lymph nodes can be performed in non-obese women, allowing a quicker release from the hospital, a quicker recovery, and where applicable, an earlier return to work. Complications of surgery include infection, bleeding and injury to the bladder, rectum or ureter causing a leak (rare). There may also be blood clots in the legs, occasionally dislodging and traveling to the lungs (pulmonary embolism). Radiation In the past, women who have Stages Ib, Ic, or IIa uterine cancer were often treated two to six weeks after surgery with radiation to the entire pelvis and upper vagina. External beam radiation was given daily, five days a week for four to five weeks. Although pelvic external beam radiation therapy will decrease the frequency of recurrences in the pelvis and vagina, it does not statistically improve the five-year survival rate and as a result is recommended less often today. Intracavitary radiation (radioactive material temporarily placed directly into or near the tumor) is used in certain cases, as well. The radioactive material is of different types and left in placed for different amount of time depending on a number of factors, including size and location of the tumor, the type of radiation i.e. low-dose rate or high-dose rate (see Radiation Therapy chapter).
8 Side effects of radiation can include diarrhea, nausea and vomiting, bleeding from the bladder or rectum, vaginal scarring, intestinal obstruction, or leaks (fistulas) from the urinary or intestinal tract. Chemotherapy Treatment with chemotherapy after surgery is used for later stages of the disease and recurrent cancer. TREATMENT BY STAGE ENDOMETRIAL HYPERPLASIA Total abdominal hysterectomy and removal of both tubes and both ovaries is the treatment of choice when fertility is no longer an issue or when progestational hormone therapy is contraindicated. For those women who desire more children or preservation of the uterus, a D&C, therapy with oral progestational agents, induction of ovulation and avoidance of postmenopausal estrogen therapy without progesterone is frequently effective. Careful followup with an endometrial biopsy or a D&C is necessary. STAGE IA The tumor is limited to the endometrium. Standard Treatment Standard therapy is removal of the uterus, both tubes and ovaries, the pelvic and aortic lymph nodes. Unfortunately, the precise grade and depth of uterine wall invasion cannot be definitely determined at the time of surgery in women thought to be stage I prior to surgery. As a result, the pelvic lymph nodes and aortic lymph nodes should be removed
9 in all patients with Grade 2 or 3 cancer, and sometimes with Grade 1. Postoperative radiation therapy is not required. Five-Year Survival 95 percent. Investigational The most significant study in progress is whether postoperative pelvic radiation therapy improves survival in women with intermediate or high-grade cancers. Laparoscopic surgery. STAGE IB The tumor invades the uterine wall, but through less than half of its thickness. Standard Treatment The abdominal removal of the uterus, both tubes and ovaries, removal of the pelvic and para-aortic lymph nodes, and abdominal washings is all that is required. Five-Year Survival Up to 85 percent. Investigational The most significant study in progress is whether postoperative pelvic radiation therapy improves survival. Laparoscopic surgery.
10 STAGE IC The tumor invades the uterine wall by more than half of its thickness. Standard Treatment Surgery is the same as Stage IB. Some gynecologic oncologists recommend whole pelvis radiation after surgery to decrease the frequency of recurrent disease in the vagina and pelvis. Although it does not statistically improve the five-year survival rate, it is effective in decreasing the incidence of local recurrences in the field of radiation. Five-Year Survival Up to 75 percent. STAGE IIA The glands that line the cervix are involved. Standard Treatment This stage is generally treated like Stage IB. Five-Year Survival Up to 70 percent. Investigational See Stage Ib. STAGE IIB The tumor cells invade the cervix. Standard Treatment Before surgery, whole-pelvis external beam radiation therapy is given five days a week, over five weeks. After a two-week break, this is followed by a 2-3 day application
11 of radioactive cesium to the upper vagina, cervix and uterus or by high-dose rate brachytherapy (see Radiation Therapy). Six weeks later, an abdominal hysterectomy is performed, along with removal of both tubes and ovaries, pelvic and aortic lymph node dissection and cytological assessment of the abdominal cavity. Alternative therapy for younger, women in good medical condition is a radical abdominal hysterectomy, removal of the tubes and ovaries, removal of all the pelvic and aortic lymph nodes and surgical staging. Five-Year Survival Up to 60 percent. Investigational Studies are looking at the role of adjuvant chemotherapy with Adriamycin, mitoxantrone, cisplatin, Cytoxan, carboplatin, Taxol, ifosfamide, Doxil, Topotecan, or progestational hormones in various regimens and doses. High-dose rate brachytherapy (see Radiation Therapy). STAGE IIIA This stage is defined by involvement of the uterine surface and/or the tubes and ovaries and/or the presence of malignant cells in the abdominal fluid (positive peritoneal washings). Standard Treatment After surgery, the type of additional treatment is controversial and should be considered investigational as there is not enough information about the risk of recurrence,
12 prognosis, and benefit of therapy. The chance of malignant cells being present within the abdominal cavity (Stage IIIa) increases with higher grades of cancer and with deeper invasion of the tumor into the uterine wall. There is much controversy over the significance of malignant cells floating in the abdominal cavity. Many gynecologic oncologists recommend treatment with radiation therapy to the entire abdomen, intra-abdominal radioactive substances such as chromic phosphate, progestational hormone therapy, or intravenous or intraperitoneal combination chemotherapy. Five-Year Survival Up to 60 percent. Investigational Postoperative pelvic radiation. Pelvic and whole-abdomen radiation. Intravenous combination chemotherapy with Taxol, cisplatin or carboplatin and Adriamycin, Doxil, or Topotecan in various doses and schedules. Intra-abdominal chemotherapy (cisplatin or carboplatin). Occasionally high-dose progestational hormones. Intra-abdominal radiation (radioactive phosphorus). STAGE IIIB Vaginal metastases.
13 Standard Treatment This stage is generally treated by abdominal hysterectomy, removal of the tubes and ovaries on both sides, thorough staging and, occasionally, surgical excision of the metastases. These cases are then usually treated with external beam radiation therapy to the pelvis and vagina, five days a week for four to five weeks. This is followed by either a temporary cesium insertion or the placing of radioactive iridium directly into the cancer (interstitial implant). Sometimes radiation therapy precedes surgery. Endometrial cancer that extends locally outside the uterus is usually treated with radiation therapy-five weeks of external radiation therapy to the pelvis followed by two temporary cesium insertions two weeks apart or by a radioactive interstitial implant (low-dose rate or high-dose rate see Radiation Therapy)-followed by surgery, if possible. Five-Year Survival Up to 40 percent. Investigational See Stage IIb. STAGE IIIC Metastases to the pelvic and/or aortic lymph nodes. Standard Treatment After surgery, women with positive pelvic and negative aortic lymph nodes receive external beam pelvic radiation therapy. If the para-aortic lymph nodes are involved, radiation therapy to the aortic region is given, as well.
14 Many gynecologic oncologists also recommend adjuvant chemotherapy such as cisplatin or carboplatin or Taxol + Adriamycin for women with positive pelvic and/or aortic node metastases. Five-Year Survival Up to 60 percent. Investigational Pelvic and para-aortic radiation versus chemotherapy (various drugs and doses). STAGE IVA The tumor invades the bladder or rectum. Standard Treatment Treatment of cancer involving the bladder or rectum is usually by external radiation therapy to the pelvis followed by two insertions of radioactive cesium or interstitial radiation with iridium inserted directly into the tumor. Another alternative is whole-pelvis radiation therapy followed by the surgical removal of the uterus, vagina, bladder and/or rectum (pelvic exenteration) is another acceptable therapy. Five-Year Survival Up to 10 percent.
15 Investigational Studies are looking at the role of adjuvant chemotherapy with Adriamycin, mitoxantrone, cisplatin, Cytoxan, carboplatin, ifosfamide, Taxol, Topotecan, Doxil or progestational hormones in various doses and regimens. STAGE IVB Distant metastases, intra-abdominal spread or disease in the lymph nodes of the groin. Standard Treatment Treatment is based on the location of the distant metastasis, with the most common sites being the lungs or liver. Therapy is rarely curative, but may be palliative. There is a 20-to 30 percent response rate to progestational hormones. If the metastatic cancer or the initial uterine tumor is sensitive to progestational hormones, as shown by the number of progesterone receptors it contains, then the response rate to hormone therapy will be significantly higher. The most commonly used progestational agent is Megace. Similarly, if the tumor contains many estrogen receptors, then anti-estrogen therapy with tamoxifen may be effective with a response rate of 20 to 30 percent. Sometimes the two hormones are used together. Chemotherapy with carboplatin or cisplatin or Taxol + Adriamycin every three to four weeks has been shown to be effective in some patients, with response rates in the range of percent.
16 Chemotherapy is frequently given alone to those women whose tumors are estrogen and progesterone receptor negative. Women with very small intra-abdominal metastases can be treated with intra-abdominal chemotherapy (cisplatin or carboplatin). Occasionally, palliative radiation therapy may be given to a localized distant metastasis. Five-Year Survival Up to 5 percent. Investigational Chemotherapeutic drugs given in various doses and combinations are being studied. These include cisplatin, carboplatin, Taxol, Adriamycin, mitoxantrone, Cytoxan, ifosfamide, 5-fluorouracil, methotrexate, Topotecan, Doxil with or without progestational hormones or antiestrogenic drugs. TREATMENT FOLLOW-UP Most gynecologic oncologists recommend a general physical and pelvic examination including a Pap smear every three months for the first two years, then every six months for another three years. The serum CA-125 level can be monitored if it was elevated before therapy. X-ray studies are done whenever specific signs and symptoms warrant.
17 RECURRENT CANCER Approximately 70 percent of recurrences take place within three years of the initial therapy. Symptoms of recurrent cancer may include vaginal bleeding or discharge, pain in the pelvis, abdomen, back or legs, leg swelling (edema), weight loss and chronic cough. Local recurrences-those on the pelvic wall, in the vagina and the tissue surrounding the cervix and uterus (parametrium)-are the most common sites in women who have not received pelvic radiation; distant metastases to the lung, liver or abdominal cavity may also occur. Radiation therapy, if not given previously, may cure those women with a vaginal or parametrial recurrence. In women who have a localized vaginal recurrence involving the bladder or rectum, the removal of the bladder and/or rectum and vagina (pelvic exenteration) can be curative in up to 40 to 50 percent of cases. Unfortunately, most women with recurrent endometrial cancer outside the pelvis cannot be cured. But symptoms may be relieved with progestational therapy, anti-estrogen therapy or chemotherapy as noted above. ESTROGEN REPLACEMENT THERAPY In the past, estrogen replacement therapy has been given to women with a low risk of recurrent cancer. Its safety, however, is unproven and as a result, the Gynecologic
18 Oncology Group is conducting a study looking at its safety. It will be several years until the final answer is known. Until then, its use should be carefully considered. THE MOST IMPORTANT QUESTIONS YOU CAN ASK What qualifications do you have for treating uterine cancer? Will a specialist in gynecologic oncology be involved in my case? Can my surgery be performed using minimally invasive surgical techniques (laparoscopy)? Why do I need radiation therapy? Is chemotherapy of any benefit? What symptoms of recurrent cancer should I be looking for after treatment? Can I use estrogen replacement therapy?
EVERYONE S GUIDE FOR CANCER THERAPY Malin Dollinger, MD, Ernest H. Rosenbaum, MD, Margaret Tempero, MD, and Sean Mulvihill, MD 4 th Edition 2001 Uterus: Uterine Sarcomas Jeffrey L. Stern, MD Uterine sarcomas
Understanding Your Diagnosis of Endometrial Cancer A STEP-BY-STEP GUIDE Introduction This guide is designed to help you clarify and understand the decisions that need to be made about your care for the
Invasive Cervical Cancer Kathleen M. Schmeler, MD Associate Professor Department of Gynecologic Oncology Cervical Cancer Etiology Human Papilloma Virus (HPV): Detected in 99.7% of cervical cancers Cancer
Endometrial Hyperplasia & Carcinoma * David Engle, MD, MS, FACOG Associate Professor, Dept. of OB/GYN University of Alabama Division of Gynecologic Oncology Huntsville Hospital *Based on APGO Student objectives
Uterine Cancer Understanding your diagnosis Uterine Cancer Understanding your diagnosis When you first hear that you have cancer, you may feel alone and afraid. You may be overwhelmed by the large amount
WOMENCARE A Healthy Woman is a Powerful Woman (407) 898-1500 Perimenopausal Bleeding and Bleeding After Menopause During perimenopause, your periods may become less predictable. These changes are common.
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Adjuvant Therapy for Breast
32 Gestational Trophoblastic Tumors C58.9 Placenta SUMMARY OF CHANGES Gestational trophoblastic tumors are effectively treated with chemotherapy even when widely metastatic so that traditional anatomic
Uterine Cancer Understanding your diagnosis Uterine Cancer Understanding your diagnosis When you first hear that you have cancer, you may feel alone and afraid. You may be overwhelmed by the large amount
UTERINE SARCOMA What is cancer? Cancer develops when cells in a part of the body begin to grow out of control. Although there are many kinds of cancer, they all start because of out-of-control growth of
Ovarian Cancer in Georgia, 1999-23 Georgia Department of Human Resources Division of Public Health Acknowledgments Georgia Department of Human Resources......B. J. Walker, Commissioner Division of Public
Abnormal Uterine Bleeding WOMENCARE A Healthy Woman is a Powerful Woman (407) 898-1500 Abnormal uterine bleeding is one of the most common reasons women see their doctors. It can occur at any age and has
Treatment Guide Gynecologic Cancer Cleveland Clinic experts tailor treatment to their patients needs, taking into account the type of cancer, the degree to which the cancer has spread, the age of the individual
Endometrial Cancer What is endometrial cancer? Let us explain it to you. www.anticancerfund.org www.esmo.org ESMO/ACF Patient Guide Series based on the ESMO Clinical Practice Guidelines ENDOMETRIAL CANCER:
PROGNOSTIC FACTORS IN ADVANSED OVARIAN CANCER Dr. Hisham Rahahle Gynecologist, MD, Ph.D Subspecialty in Gynecological Oncology E-mail: firstname.lastname@example.org Abstract: This study includes (68) patient diagnosed
Hysterectomy removal of the uterus is a way of treating problems that affect the uterus. Many conditions can be cured with hysterectomy. Because it is major surgery, your doctor may suggest trying other
Gallbladder cancer Gallbladder cancer is a disease in which malignant (cancer) cells form in the tissues of the gallbladder. Gallbladder cancer is a rare disease in which malignant (cancer) cells are found
The 2015 Cancer Program Annual Public Reporting of Outcomes/Annual Site Analysis Statistical Data from 2014 ECHN strives to provide access to enhanced cancer care and services in a comfortable environment
Overview of Gynaecologic Cancer Stuart Salfinger Gynaecologic Oncologist St John of God Hospital King Edward Memorial Hospital Cervical Cancer Cervical Cancer Risk HPV Smoking?OCP Cervical Cancer Symptoms
ENDOMETRIAL CANCER Uterine cancer is the 4thmostcommoncanceramong women in the UK (2010), accounting for 2.5% of all new cases of cancer in females In 2010, 8,288 women in the UK were diagnosed with uterine
INFORMATION LEAFLET ON TOTAL LAPAROSCOPIC RADICAL HYSTERECTOMY (TLRH) FOR EARLY STAGE CERVICAL CANCER (TREATING EARLY STAGE CERVICAL CANCER BY RADICAL HYSTERECTOMY THROUGH KEYHOLE SURGERY) Aim of the leaflet
Endometrial (Uterine) Cancer What is endometrial cancer? Endometrial cancer starts when cells in the inner lining of the uterus (endometrium) begin to grow out of control. Cells in nearly any part of the
Home > Types of Cancer > Ovarian, Fallopian Tube, and Peritoneal Cancer > Ovarian, Fallopian Tube, and Peritoneal Cancer - Treatment Options PDF generated on September 2, 2016 from http://www.cancer.net/cancer-types/ovarian-fallopian-tube-andperitoneal-cancer/treatment-options
Kate O Hanlan, M. D. F. A. C. O. G., F. A. C. S. Gynecologic Oncology, Surgery and Endoscopy 4370 Alpine Road Portola Valley, CA 94028-7523 Phone: (650)-851-6669 FAX: (650) 851-9747 Regarding Ovarian Cancer,
Endometriosis WOMENCARE A Healthy Woman is a Powerful Woman (407) 898-1500 The lining of the uterus is called the endometrium. Sometimes, endometrial tissue grows elsewhere in the body. When this happens
Ovarian Cancer Josie Rutovitz Extent of the Problem In 2006 = 9 th most common cancer in women (Aust Institute of Health and Welfare). 1226 new cases in 2006. 60% of cases are post menopausal. 47% increase
SE Scotland Cancer Network SCAN Gynaecological Group Clinical Management Protocols: Cancer of the Cervix www.scan.scot.nhs.uk Table of contents 3 Introduction 4 Diagnosis 5-6 Staging and spread of disease
AFTER DIAGNOSIS: PROSTATE CANCER Understanding Your Treatment Options INTRODUCTION This booklet describes how prostate cancer develops, how it affects the body and the current treatment methods. Although
Liver Cancer What is the liver? The liver is the largest internal organ in the body and is important in digesting food. The liver performs many other functions, including collecting and filtering blood
Summa Health System A Woman s Guide to Hysterectomy Hysterectomy A hysterectomy is a surgical procedure to remove a woman s uterus (womb). The uterus is the organ which shelters and nourishes a baby during
Why would you need a hysterectomy? Removal of the uterus is performed to prevent, alleviate, or treat pain, pressure, bleeding, or cancer. Each reason is described in detail in the following pages. Benign
RADIATION THERAPY FOR GYNECOLOGIC CANCERS Facts to Help Patients Make an Informed Decision TARGETING CANCER CARE AMERICAN SOCIETY FOR RADIATION ONCOLOGY FACTS ABOUT GYNECOLOGIC CANCERS Gynecologic cancers
Breast Cancer Introduction Cancer of the breast is the most common form of cancer that affects women but is no longer the leading cause of cancer deaths. About 1 out of 8 women are diagnosed with breast
Cervical Cancer The Importance of Cervical Screening and Vaccination Cancer Cells Cancer begins in cells, the building blocks that make up tissues. Tissues make up the organs of the body. Sometimes, this
Ovarian Cancer Understanding your diagnosis Ovarian Cancer Understanding your diagnosis When you first hear that you have cancer, you may feel alone and afraid. You may be overwhelmed by the large amount
Uterine Sarcoma Chapter 5 Fred Ueland, MD Division of Gynecologic Oncology University of Kentucky University of Kentucky Annual New Cancers 140 128 120 100 80 60 40 84 82 42 Uterus Ovary Cervix Vulva Other
Abnormal Uterine Bleeding FAQ Sheet What is abnormal uterine bleeding? Under normal circumstances, a woman's uterus sheds a limited amount of blood during each menstrual period. Bleeding that occurs between
Cystectomy and Ovarian Cysts Ovarian cysts are sacs filled with fluids or pockets located on or in an ovary. In some cases, these cysts need to be removed surgically. Types of Cysts Ovarian cysts are quite
Epithelial Ovarian Cancer Fred Ueland, MD University of Kentucky Gynecologic Oncology Risk Factors Incessant ovulation Early menarche, late menopause, low parity Family history Acquired genetic mutations
PATIENT EDUCATION patienteducation.osumc.edu Lung Cancer: Diagnosis, Staging and Treatment Cancer starts in our cells. Cells are the building blocks of our tissues. Tissues make up the organs of the body.
Hydrothermal Endometrial Ablation Introduction A hydrothermal endometrial ablation also known as HTA is a procedure that allows doctors to destroy the inner lining of the uterus. It is one way to treat
Surgical Staging of Endometrial Cancer I. Endometrial Cancer Surgical Staging Overview Uterine cancer types: carcinomas type I and type II, sarcomas, carcinosarcomas Hysterectomy with BSO Surgical Staging
Pancreatic Cancer Pancreatic cancer mainly occurs in people over 60. If it is diagnosed at an early stage, then an operation to remove the cancer followed by chemotherapy with or without radiation therapy
Emily Hill, MD Clinical Assistant Professor Gynecologic Oncology Division University of Iowa Hospitals and Clinics Learning Objectives What you need to know: Risk factors Symptoms Diagnosis/treatment Prevention
2011 We care health Services Pankaj nagpal [ Testicular Cancer Treatment In India at Mumbai At Low cost] [Type the abstract of the document here. The abstract is typically a short summary of the contents
Uterine fibroids (Leiomyoma) What are uterine fibroids? Uterine fibroids are fairly common benign (not cancer) growths in the uterus. They occur in about 25 50% of all women. Many women who have fibroids
Follow-Up Care for Endometrial (Uterus) Cancer after Discharge from the Cancer Center Disclaimer This is general information developed by The Ottawa Hospital. It is not intended to replace the advice of
An estimated 220,000 women in the United States are diagnosed with breast cancer each year, and one in eight will be diagnosed during their lifetime. While breast cancer is a serious disease, most patients
Endometrial (Uterine) Cancer Overview The information that follows is based on the more detailed information in our document Endometrial (Uterine) Cancer. You can get this document and other information
OVARIAN CYSTS Follicular Cyst Ovarian cysts are fluid-filled sacs that form within or on the ovary. The majority of these cysts are functional meaning they usually form during a normal menstrual cycle.
Corpus Uterus Cancer Figure 7 Definition: The uterus is a hollow organ in the pelvis of females. 1 There are three parts: the top is called the fundus, the middle is called the corpus, and the bottom part
Prostate Cancer OVERVIEW Prostate cancer is the second most common cancer diagnosed among American men, accounting for nearly 200,000 new cancer cases in the United States each year. Greater than 65% of
Facing a Hysterectomy? If you ve been diagnosed with early stage gynecologic cancer, learn about minimally invasive da Vinci Surgery The Condition: Early Stage Gynecologic Cancer A variety of gynecologic
WOMENCARE A Healthy Woman is a Powerful Woman (407) 898-1500 Uterine Polyps Definition Uterine polyps are growths attached to inner wall of the uterus and protruding into the uterine cavity. Overgrowth
A Patient s Guide Follow-Up Care for Breast Cancer Recommendations of the American Society of Clinical Oncology The American Society of Clinical Oncology (ASCO) is a nonprofit organization which represents
Renal cell cancer Renal cell cancer is a disease in which malignant (cancer) cells form in tubules of the kidney. Renal cell cancer (also called kidney cancer or renal adenocarcinoma) is a disease in which
Endometrial (Uterine) Cancer What is cancer? The body is made up of trillions of living cells. Normal body cells grow, divide to make new cells, and die in an orderly fashion. During the early years of
Kidney Cancer OVERVIEW Kidney cancer is the third most common genitourinary cancer in adults. There are approximately 54,000 new cancer cases each year in the United States, and the incidence of kidney
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Early Prostate Cancer:
Brad J. Cohen, MD, MBA 2477 Route 516, Suite 103, Old Bridge, New Jersey Office 732-679-6900 Fax 732-679-7900 SURGICAL CONSENT You have elected to have Dr. Brad J. Cohen perform a minimally invasive laparoscopic
AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE Laparoscopy and Hysteroscopy A Guide for Patients PATIENT INFORMATION SERIES Published by the American Society for Reproductive Medicine under the direction of
Ovarian Cysts WOMENCARE A Healthy Woman is a Powerful Woman (407) 898-1500 The ovaries are two small organs located on either side of a woman s uterus. An ovarian cyst is a sac or pouch filled with fluid
Fact sheet 2 About ovarian cancer We, Ovacome, are a support network for people affected by ovarian cancer in the UK. We provide information and support, raise awareness and put you in touch with others
PATIENT EDUCATION patienteducation.osumc.edu Lung Cancer: Diagnosis, Staging and Treatment Cancer begins in our cells. Cells are the building blocks of our tissues. Tissues make up the organs of the body.
EXTRAHEPATIC BILE DUCT CANCER General Information Extrahepatic bile duct cancer is a rare disease in which malignant (cancer) cells form in the part of bile duct that is outside the liver. A network of
Today s Woman Staying Healthy Risk Factors and Warning Signs for Women s Cancers Women s Cancer Research Institute at the Samuel Oschin Comprehensive Cancer Institute WHAT IS A GYNECOLOGIST, AND WHAT DOES
Pathology of the Endometrium Thomas C. Wright Columbia University, New York, NY Endometrium Most common diseases: Abnormal uterine bleeding Inflammatory conditions Benign neoplasms Endometrial cancer Page
Gynaecological Malignancies: Uterine Cancer Definition An epithelial malignancy of the uterine corpus mucosa, usually an adenocarcinoma.  Epidemiology Endometrial cancer is the 4 th most common cancer
Ovarian cancer A guide for journalists on ovarian cancer and its treatment Contents Contents 2 3 Section 1: Ovarian Cancer 4 i. Types of ovarian cancer 4 ii. Causes and risk factors 5 iii. Symptoms and
Cervical Cancer Understanding your diagnosis Cervical Cancer Understanding your diagnosis When you first hear that you have cancer, you may feel alone and afraid. You may be overwhelmed by the large amount
Fibroid Treatment Options A guide for patients ask4ufe.com 1-877-ASK-4-UFE Uterine Fibroids and Their Symptoms Fibroids are noncancerous growths in or on the walls of the uterus (or womb). They can range
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Metastatic Cancer: Questions
GYNAECOLOGY DEPARTMENT Should you require copies of the correspondence between the hospitals? And your family GP, Please do not hesitate to ask for this during your consultation. CANCER OF THE OVARY Patient
Saint Louis University Cancer Center GYNECOLOGIC CANCERS What you should know about gynecologic cancers. FACTS ABOUT GYNECOLOGIC CANCERS Cancers of the female reproductive organs usually occur in the cervix,
INFORMATION SHEET Cervical Cancer This information sheet has been written to provide you with information about cervical cancer (cancer of the cervix). The sheet has information about the different types
Thyroid Cancer Introduction The thyroid is a gland in the neck. Thyroid cancer is a common type of cancer. It accounts for 1% to 5% of cancer cases worldwide. As medical technology advances, more cases
Ovarian Cancer: A Case Report Abstract Ovarian cancer is a very common cancer among women. It is an extremely diverse disease requiring several treatment options. Occasionally ovarian cancer is diagnosed
Carcinoma of the Cervix Kathleen M. Schmeler, MD Associate Professor Department of Gynecologic Oncology Cervical Cancer Treatment Treatment Microinvasive (Stage IA1): Simple (extrafascial) hysterectomy/cone
Hysterectomy The time to take care of yourself The time to take care of yourself Women spend a lot of time taking care of others spouses, children, parents. We often overlook our own needs. But when our
Costing statement: Ovarian cancer: the recognition and initial management of ovarian cancer 1 Resource impact The guideline on ovarian cancer (NICE clinical guideline 122) is unlikely to have a significant
Cancer Glossary Source: National Cancer Institute: What You Need to Know About Cancer Adenoma (ad-in-oh-ma): A noncancerous tumor. Adjuvant therapy (AD-joo-vant): Treatment given after the primary treatment
X-Plain Breast Cancer Reference Summary The risk of breast cancer among Asian Americans living in the U.S. is relatively low compared to caucasian women. However, there is concern that the risk of breast
INITIAL EVALUATION History and Physical CXR Pathology review 1 Labs Consider CA125, and pre-operative imaging of abdomen and pelvis Screen for Lynch Syndrome by family history or molecular testing CLINICAL